(Q46453980)

English

Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate

scientific article published in August 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

1 reference

based on heuristic

inferred from title

Maria Trojanowska

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Peter Ten Dijke

object named as

Peter ten Dijke

7

0 references

author name string

Jaspreet Pannu

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Yoshihide Asano

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Sashidhar Nakerakanti

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Edwin Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Stefania Jablonska

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Maria Blaszczyk

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

publication date

1 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

58

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

2528-2537

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin

1 reference

https://api.crossref.org/works/10.1002%2FART.23698

21 January 2018

Identifiers

10.1002/ART.23698

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18668566

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46453980&oldid=2112436760"